NCT07122453View on ClinicalTrials.gov

Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Lower Back Pain
Interventions
DRUG

CNTX-3001

non-opioid analgesic

DRUG

Placebo

Placebo product

Trial Locations (1)

94558

Neurovations, Napa

Sponsors
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Centrexion Therapeutics

INDUSTRY